Harvard Bioscience Cash on Hand 2012-2026 | HBIO
Harvard Bioscience cash on hand from 2012 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
Harvard Bioscience Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $9 |
| 2024 | $4 |
| 2023 | $4 |
| 2022 | $5 |
| 2021 | $8 |
| 2020 | $8 |
| 2019 | $8 |
| 2018 | $8 |
| 2017 | $5 |
| 2016 | $6 |
| 2015 | $7 |
| 2014 | $14 |
| 2013 | $26 |
| 2012 | $21 |
| 2011 | $18 |
|
Harvard Bioscience Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2026-03-31 | $7 |
| 2025-12-31 | $9 |
| 2025-09-30 | $7 |
| 2025-06-30 | $7 |
| 2025-03-31 | $6 |
| 2024-12-31 | $4 |
| 2024-09-30 | $5 |
| 2024-06-30 | $4 |
| 2024-03-31 | $4 |
| 2023-12-31 | $4 |
| 2023-09-30 | $5 |
| 2023-06-30 | $4 |
| 2023-03-31 | $4 |
| 2022-12-31 | $5 |
| 2022-09-30 | $5 |
| 2022-06-30 | $4 |
| 2022-03-31 | $5 |
| 2021-12-31 | $8 |
| 2021-09-30 | $6 |
| 2021-06-30 | $6 |
| 2021-03-31 | $6 |
| 2020-12-31 | $8 |
| 2020-09-30 | $3 |
| 2020-06-30 | $3 |
| 2020-03-31 | $6 |
| 2019-12-31 | $8 |
| 2019-09-30 | $7 |
| 2019-06-30 | $5 |
| 2019-03-31 | $5 |
| 2018-12-31 | $8 |
| 2018-09-30 | $7 |
| 2018-06-30 | $6 |
| 2018-03-31 | $6 |
| 2017-12-31 | $5 |
| 2017-09-30 | $6 |
| 2017-06-30 | $5 |
| 2017-03-31 | $5 |
| 2016-12-31 | $6 |
| 2016-09-30 | $5 |
| 2016-06-30 | $4 |
| 2016-03-31 | $4 |
| 2015-12-31 | $7 |
| 2015-09-30 | $6 |
| 2015-06-30 | $7 |
| 2015-03-31 | $8 |
| 2014-12-31 | $14 |
| 2014-09-30 | $27 |
| 2014-06-30 | $26 |
| 2014-03-31 | $26 |
| 2013-12-31 | $26 |
| 2013-09-30 | $37 |
| 2013-06-30 | $34 |
| 2013-03-31 | $24 |
| 2012-12-31 | $21 |
| 2012-09-30 | $20 |
| 2012-06-30 | $19 |
| 2012-03-31 | $17 |
| 2011-12-31 | $18 |
| 2011-09-30 | $16 |
| 2011-06-30 | $22 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $0.019B | $0.087B |
| HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bruker (BRKR) | United States | $5.722B | 20.54 |
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |